全文获取类型
收费全文 | 26710篇 |
免费 | 1265篇 |
国内免费 | 214篇 |
专业分类
耳鼻咽喉 | 323篇 |
儿科学 | 509篇 |
妇产科学 | 306篇 |
基础医学 | 3309篇 |
口腔科学 | 423篇 |
临床医学 | 1661篇 |
内科学 | 7504篇 |
皮肤病学 | 538篇 |
神经病学 | 1806篇 |
特种医学 | 1286篇 |
外科学 | 4441篇 |
综合类 | 105篇 |
预防医学 | 682篇 |
眼科学 | 469篇 |
药学 | 1595篇 |
中国医学 | 72篇 |
肿瘤学 | 3160篇 |
出版年
2023年 | 178篇 |
2022年 | 404篇 |
2021年 | 672篇 |
2020年 | 341篇 |
2019年 | 451篇 |
2018年 | 645篇 |
2017年 | 516篇 |
2016年 | 603篇 |
2015年 | 632篇 |
2014年 | 777篇 |
2013年 | 986篇 |
2012年 | 1561篇 |
2011年 | 1783篇 |
2010年 | 1061篇 |
2009年 | 943篇 |
2008年 | 1584篇 |
2007年 | 1639篇 |
2006年 | 1681篇 |
2005年 | 1687篇 |
2004年 | 1655篇 |
2003年 | 1524篇 |
2002年 | 1474篇 |
2001年 | 437篇 |
2000年 | 409篇 |
1999年 | 460篇 |
1998年 | 343篇 |
1997年 | 266篇 |
1996年 | 212篇 |
1995年 | 215篇 |
1994年 | 186篇 |
1993年 | 172篇 |
1992年 | 270篇 |
1991年 | 244篇 |
1990年 | 207篇 |
1989年 | 221篇 |
1988年 | 178篇 |
1987年 | 170篇 |
1986年 | 174篇 |
1985年 | 159篇 |
1984年 | 132篇 |
1983年 | 103篇 |
1982年 | 54篇 |
1981年 | 72篇 |
1980年 | 59篇 |
1979年 | 69篇 |
1978年 | 49篇 |
1977年 | 67篇 |
1975年 | 42篇 |
1971年 | 44篇 |
1969年 | 43篇 |
排序方式: 共有10000条查询结果,搜索用时 9 毫秒
31.
32.
Masatoshi Kubo Shigeharu Moriyama Tomohiro Nogami Tadayoshi Kunitomo Sugato Nawa 《The Japanese Journal of Thoracic and Cardiovascular Surgery》2004,52(9):435-438
This paper presents a case of intercostal hemangioma, in which a complete surgical resection was accomplished based upon a
tentative diagnosis provided by magnetic resonance imaging (MRI). A 27-year-old man visited our hospital for the evaluation
of chest pain and shortness of breath after exertion. Computed tomography showed a soft tissue mass, 5.5×3.5 cm in size, arising
from the right lateral 7th intercostal space. Dynamic MRI showed that the mass was enhanced rapidly in the early phase and
that this early enhancement was maintained during the delayed phase, which was compatible with a diagnosis of intercostal
hemangioma. The patient underwent surgery, and a complete resection of the tumor with the right 7th and 8th ribs and their
intercostal muscles was accomplished. Histopathological examination confirmed the diagnosis of intramuscular hemangioma of
the large-vessel type. Presently, 6 months after the operation, the patient is doing well, without any evidence of local recurrence. 相似文献
33.
34.
Hiroki Sakamoto Masayuki Kitano Takeshi Nishio Yoshifumi Takeyama Chikao Yasuda Masatoshi Kudo 《Digestive endoscopy》2006,18(3):206-211
Endosonography‐guided celiac plexus neurolysis (EUS‐CPN) safely and effectively relieves pain associated with intra‐abdominal malignancies when the neurolytic is accurately injected. We applied contrast medium to evaluate the ethanol injection sites in patients who received EUS‐CPN due to abdominal pain caused by malignancies. We injected, under the guidance of endoscopic ultrasonography (EUS), ethanol containing 10% contrast medium into the celiac plexus of patients with intra‐abdominal pain due to malignancies. Immediately after the endoscopic therapy, patients underwent computed tomography (CT) to confirm the injection site. Images of distribution of injected solutions were classified into three groups. Injected solution dispersed in unilateral and bilateral anterocrural space was defined as ‘unilateral injection’ or ‘bilateral injection’, respectively. Injected solution located out of the anterocrural space was defined as ‘inappropriate injection’. Pre‐ and postprocedure pain was assessed using a standard analog scale. Before and 2, 4, 8, 12, and 16 weeks after the procedure, pain scores were evaluated. From April 2003 to May 2005, 13 patients were enrolled in this study. Improvement of pain score in the ‘bilateral injection’ and ‘unilateral injection’ groups was significantly superior to the change in the ‘inappropriate injection’ group. Although EUS‐CPN was effective in eight of 13 patients (61.5%), additional EUS‐CPN to the ‘inappropriate injection group’ increased the response rate to 84.6%. Injection of ethanol to the anterocrural space by EUS‐CPN produced adequate pain relief. Immediate examination by CT for confirmation of injection sites after EUS‐CPN would increase the likelihood of induction of pain relief. 相似文献
35.
Masashi Okuro Shigeto Morimoto Takashi Takahashi Kohya Okaishi Takeshi Nakahashi Hiroshi Murai Kunimitsu Iwai Tsugiyasu Kanda Masayuki Matsumoto 《Hypertension research》2006,29(9):655-663
Endothelial function in elderly hypertensive patients with arteriosclerosis obliterans has not been evaluated. We examined whether antihypertensive drugs improve vasodilatory response to reactive hyperemia of the limbs in elderly hypertensive patients (83 +/- 8 [SD] years) without (n=46, 0.9 < or = ankle-brachial pressure index < or = 1.4) and with (n=24) arteriosclerosis obliterans (ankle-brachial pressure index < 0.2). Patients were randomized for treatment with monotherapy of either temocapril (14 with and 26 without arteriosclerosis obliterans) or amlodipine (10 with and 20 without arteriosclerosis obliterans) for 6 months. Blood flows of the forearms and legs were measured by strain-gauge plethysmography. The vasodilatory response to the release of compression of the forearms and thighs at 200 mmHg or 20 mmHg more than systolic blood pressure for 5 min and to sublingual administration of nitroglycerin (0.3 mg) was assessed. The maximum reactive hyperemic flow in 35 legs with arteriosclerosis obliterans was significantly (p < 0.001) decreased compared to the value in legs in the control hypertensive subjects. Moreover, maximum reactive hyperemic flow in the forearms of patients with arteriosclerosis obliterans was significantly (p = 0.002) decreased compared to that in the control subjects. Blood pressure was similarly decreased by treatment with temocapril or amlodipine. Response to nitroglycerin (0.3 mg) was not changed by either drug. Treatment with temocapril significantly improved maximum reactive hyperemic flow of not only the legs and forearms in control hypertensives but also the legs and forearms in patients with arteriosclerosis obliterans, and attenuated the worsening of activity of daily living in these patients, although treatment with amlodipine did not. These results suggest that the angiotensin-converting enzyme inhibitor temocapril has a beneficial effect on endothelial function in elderly patients with arteriosclerosis obliterans. 相似文献
36.
We reported a case of photoleukomelanodermatitis (Kobori) type drug eruption due to afloqualone (Arofuto®). The patient was given afloqualone and imipramine hydrochloride (Chrytemin®) for cervical spondylosis from November of 1990. Edematous erythema with slight itching appeared on the sun-exposed areas in December of 1990. As drug eruption was suspected, drugs were ceased, and the cutaneous lesions almost disappeared but pigmentations and depigmentations developed in spots in sun-exposed areas in March of 1991. Photopatch and oral challenge tests were positive. 相似文献
37.
The angiographic features of left spontaneous carotid-cavernous sinus fistula and multiple dural arteriovenous malformations that developed after transvenous embolization are described. A dural arteriovenous malformation involving the left sigmoid sinus was demonstrated, along with a marked decrease in size of the left carotid-cavernous sinus fistula and the disappearance of venous drainage from the left cavernous to the right cavernous sinus after embolization with spring coils via the left superior ophthalmic vein. The dural arteriovenous malformation of the left sigmoid sinus subsequently extended to the transverse sinus after partial embolization of the sigmoid sinus. Finally, a dural arteriovenous malformation involving the left transverse sinus developed, with the disappearance of the arteriovenous malformation affecting the sigmoid sinus and left carotid-cavernous sinus fistula following complete embolization of the sigmoid sinus via the left transverse sinus. 相似文献
38.
Peritumoral brain edema associated with meningioma--histological study of the tumor margin and surrounding brain. 总被引:2,自引:0,他引:2
Thirty-nine cases of intracranial meningiomas were analyzed to identify factors causing brain edema. Edema was significantly correlated with tumor size and the destruction of the leptomeninges and cortex. Meningotheliomatous meningioma tended to have more peritumoral edema. There was no correlation between the presence of edema and location of the tumor or histological features including lymphocytic infiltration and the presence of glial fibrillary acidic protein-positive cells in the tumor tissue. Larger tumors destroy the leptomeninges and cerebral cortex, allowing direct transmission of humoral edema-promoting factor or edema fluid into the white matter, resulting in vasogenic edema. 相似文献
39.
40.
E Ohshima H Takami H Sato S Mohri H Obase I Miki A Ishii S Shirakura A Karasawa K Kubo 《Journal of medicinal chemistry》1992,35(18):3402-3413
A series of 11-[2-(1-benzimidazolyl)ethylidene]-6,11-dihydrodibenz[b,e]oxep in-2- carboxylic acid derivatives and related compounds were synthesized and found to be potent TXA2/PGH2 receptor antagonists. Each compound synthesized was tested for its ability to displace [3H]U-46619 binding from guinea pig platelet TXA2/PGH2 receptors. Structure-activity relationship studies revealed that the following key elements were required for enhanced activities: (1) an (E)-2-(1-benzimidazolyl)ethylidene side chain in the 11-position of the dibenzoxepin ring system and (2) a carboxyl group in the 2-position of the dibenzoxepin ring system. The studies also indicated that the TXA2/PGH2 receptor binding affinities of this series of compounds in guinea pig platelet were poorly correlated with those in human platelet. Introduction of substituent(s) to the benzimidazole moiety was effective and sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)ethylidene]- 6,11-dihydrodibenz[b,e]oxepin-2-carboxylate monohydrate (57) recorded the highest affinity for human platelet TXA2/PGH2 receptor with a K(i) value of 1.2 +/- 0.14 nM. It demonstrated potent inhibitory effects on U-46619-induced guinea pig platelet aggregation (in vitro and ex vivo) and human platelet aggregation (in vitro). Compound 57, now designated as KW-3635, is a novel, orally active, and specific TXA2/PGH2 receptor antagonist with neither TXA2/PGH2 receptor agonistic nor TXA2 synthase inhibitory effects. It is now under clinical evaluation. 相似文献